Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery in Subjects Undergoing Bowel Resection
Public ClinicalTrials.gov record NCT04742907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of TU-100 as an Adjunct to an Enhanced Recovery After Surgery (ERAS) Protocol in Subjects Undergoing Bowel Resection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multicenter, randomized, double-blinded, placebo-controlled study will evaluate the effect of TU-100 on resolution of postoperative ileus (POI) in subjects undergoing open or laparoscopic bowel resection (BR).
Study identification
- NCT ID
- NCT04742907
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 402 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2021 (Actual)
- Primary completion
- Mar 25, 2024 (Actual)
- Completion
- May 1, 2024 (Actual)
- Last update posted
- Apr 16, 2025
2021 – 2024
United States locations
- U.S. sites
- 36
- U.S. states
- 22
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Florence Site | Florence | Alabama | 35630 | — |
| Gilbert Site | Gilbert | Arizona | 85234 | — |
| Little Rock Site | Little Rock | Arkansas | 72205 | — |
| Duarte Site | Duarte | California | 91010 | — |
| Los Angeles Site #1 | Los Angeles | California | 90033 | — |
| Los Angeles Site #2 | Los Angeles | California | 90048 | — |
| Palo Alto Site | Palo Alto | California | 94304 | — |
| Sacramento Site | Sacramento | California | 95817 | — |
| Danbury Site | Danbury | Connecticut | 06810 | — |
| Clearwater Site | Clearwater | Florida | 33756 | — |
| Orlando Site | Orlando | Florida | 32803 | — |
| Tampa Site | Tampa | Florida | 33606 | — |
| Weston Site | Weston | Florida | 33331 | — |
| Chicago Site #2 | Chicago | Illinois | 60612 | — |
| Chicago Site #1 | Chicago | Illinois | 60637 | — |
| Urbana Site | Urbana | Illinois | 61801 | — |
| Lexington Site | Lexington | Kentucky | 40536 | — |
| Metairie Site | Metairie | Louisiana | 70006 | — |
| Boston Site #1 | Boston | Massachusetts | 02115 | — |
| Detroit Site | Detroit | Michigan | 48201 | — |
| St. Louis Site | St Louis | Missouri | 63110 | — |
| Newark Site | Newark | New Jersey | 07103 | — |
| Mineola Site | Mineola | New York | 11501 | — |
| New York Site | New York | New York | 10065 | — |
| Stony Brook Site | Stony Brook | New York | 11794 | — |
| Cleveland Site #2 | Cleveland | Ohio | 44111 | — |
| Cleveland Site #1 | Cleveland | Ohio | 44195 | — |
| Philadelphia Site #2 | Philadelphia | Pennsylvania | 19140 | — |
| Pittsburgh Site | Pittsburgh | Pennsylvania | 15212 | — |
| Charleston Site | Charleston | South Carolina | 29425 | — |
| Memphis Site | Memphis | Tennessee | 38120 | — |
| Dallas Site | Dallas | Texas | 75246 | — |
| Fort Worth Site | Fort Worth | Texas | 76104 | — |
| Salt Lake City Site | Salt Lake City | Utah | 84132 | — |
| Roanoke Site | Roanoke | Virginia | 24014 | — |
| Milwaukee Site | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04742907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2025 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04742907 live on ClinicalTrials.gov.